Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Ciron

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
Revue Neurologique|April 29, 2018
First-line therapy in relapsing remitting multiple sclerosisD Biotti, J Ciron
Revue Neurologique|September 28, 2021
Late-onset neutropenia after anti-CD20 therapy for multiple sclerosis, neuromyelitis optica spectrum disorders and MOG antibody-associated disease: A prospective studyJ Rigal, D Biotti, Z Lépine, et al.
Multiple Sclerosis and Related Disorders|March 11, 2020
Late-onset neutropenia after RITUXIMAB therapy for multiple sclerosis, neuromyelitis optica spectrum disorders and MOG-antibody-associated diseasesJ Rigal, J Ciron, Z Lépine, et al.
Multiple Sclerosis and Related Disorders|September 17, 2020
Off-label use of tocilizumab in neuromyelitis optica spectrum disorders and MOG-antibody-associated diseases: A case-seriesJ Rigal, G Pugnet, J Ciron, et al.
La Revue De Medecine Interne|June 15, 2007
[Solitary intracerebral langerhans cell histiocytosis: report of one case and literature review]S Mathis, P Levillain, P Vandermarcq, et al.
Neurophysiologie Clinique = Clinical Neurophysiology|February 15, 2011
Study of accessory deep peroneal nerve motor conduction in a population of healthy subjectsS Mathis, J Ciron, F du Boisguéheneuc, et al.
Revue Neurologique|January 9, 2023
Paradigm shifts in multiple sclerosis management: Implications for daily clinical practiceB Bourre, O Casez, J Ciron, et al.
Revue Neurologique|April 3, 2018
Recommendations for the use of Rituximab in neuromyelitis optica spectrum disordersJ Ciron, B Audoin, B Bourre, et al.
Revue Neurologique|December 28, 2010
[Vitamin D and multiple sclerosis. A prospective survey of patients of Poitou-Charentes area]J P Neau, M S Artaud-Uriot, V Lhomme, et al.
Revue Neurologique|September 30, 2022
Secondary progressive multiple sclerosis: A national consensus paper on diagnostic criteriaJ Ciron, A Gueguen, A Al Khedr, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Revue Neurologique|April 29, 2018
First-line therapy in relapsing remitting multiple sclerosisD Biotti, J Ciron
Revue Neurologique|September 28, 2021
Late-onset neutropenia after anti-CD20 therapy for multiple sclerosis, neuromyelitis optica spectrum disorders and MOG antibody-associated disease: A prospective studyJ Rigal, D Biotti, Z Lépine, et al.
Multiple Sclerosis and Related Disorders|March 11, 2020
Late-onset neutropenia after RITUXIMAB therapy for multiple sclerosis, neuromyelitis optica spectrum disorders and MOG-antibody-associated diseasesJ Rigal, J Ciron, Z Lépine, et al.
Multiple Sclerosis and Related Disorders|September 17, 2020
Off-label use of tocilizumab in neuromyelitis optica spectrum disorders and MOG-antibody-associated diseases: A case-seriesJ Rigal, G Pugnet, J Ciron, et al.
La Revue De Medecine Interne|June 15, 2007
[Solitary intracerebral langerhans cell histiocytosis: report of one case and literature review]S Mathis, P Levillain, P Vandermarcq, et al.
Neurophysiologie Clinique = Clinical Neurophysiology|February 15, 2011
Study of accessory deep peroneal nerve motor conduction in a population of healthy subjectsS Mathis, J Ciron, F du Boisguéheneuc, et al.
Revue Neurologique|January 9, 2023
Paradigm shifts in multiple sclerosis management: Implications for daily clinical practiceB Bourre, O Casez, J Ciron, et al.
Revue Neurologique|April 3, 2018
Recommendations for the use of Rituximab in neuromyelitis optica spectrum disordersJ Ciron, B Audoin, B Bourre, et al.
Revue Neurologique|December 28, 2010
[Vitamin D and multiple sclerosis. A prospective survey of patients of Poitou-Charentes area]J P Neau, M S Artaud-Uriot, V Lhomme, et al.
Revue Neurologique|September 30, 2022
Secondary progressive multiple sclerosis: A national consensus paper on diagnostic criteriaJ Ciron, A Gueguen, A Al Khedr, et al.
Pageof 2